Menu
Back to User profile » Prof. Dr. Shih-Lung Cheng
Papers published by Prof. Dr. Shih-Lung Cheng:
Current Progress of COPD Early Detection: Key Points and Novel Strategies
Lin CH, Cheng SL, Chen CZ, Chen CH, Lin SH, Wang HC
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:1511-1524
Published Date: 19 July 2023
The Benefits of Molnupiravir Treatment in Healthcare Facilities Patients with COVID-19
Cheng SL, Wang PH, Chang CY, Wang HH, Wang CJ, Chiu KM
Drug Design, Development and Therapy 2023, 17:87-92
Published Date: 19 January 2023
Comparing Clinical Outcomes of Tiotropium/Olodaterol, Umeclidinium/Vilanterol, and Indacaterol/Glycopyrronium Fixed-Dose Combination Therapy in Patients with Chronic Obstructive Pulmonary Disease in Taiwan: A Multicenter Cohort Study
Hsieh MJ, Chen NH, Cheng SL, Tao CW, Wei YF, Wu YK, Chan MC, Liu SF, Hsu WH, Yang TM, Lin MS, Liu CL, Kuo PH, Tsai YH
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:967-976
Published Date: 27 April 2022
Performance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools
Chen CZ, Sheu CC, Cheng SL, Wang HC, Lin MC, Hsu WH, Lee KY, Perng DW, Lin HI, Lin MS, Lin SH, Tsai JR, Wang CC, Wang CY, Yang TM, Liu CL, Wang TY, Lin CH
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3405-3415
Published Date: 18 December 2021
Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan
Cheng SL, Li YR, Huang N, Yu CJ, Wang HC, Lin MC, Chiu KC, Hsu WH, Chen CZ, Sheu CC, Perng DW, Lin SH, Yang TM, Lin CB, Kor CT, Lin CH
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2869-2881
Published Date: 18 October 2021
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus as-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in patients Without Optimally Controlled asthma (REACT) Study [Corrigendum]
Cheng SL, Ho ML, Lai YF, Wang HC, Hsu JY, Liu SF, Huang MS, Lee CH, Lin CH, Hang LW, Liu YC, Yang KY, Wang JH
Drug Design, Development and Therapy 2021, 15:515-516
Published Date: 12 February 2021
Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β2 Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study
Cheng SL, Ho ML, Lai YF, Wang HC, Hsu JY, Liu SF, Huang MS, Lee CH, Lin CH, Hang LW, Liu YC, Yang KY, Wang JH
Drug Design, Development and Therapy 2020, 14:5441-5450
Published Date: 8 December 2020
Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
Cheng SL
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2775-2784
Published Date: 6 September 2018
Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
Cheng S, Wang HH, Lin C
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2231-2238
Published Date: 31 July 2017